Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy (vol 8, 586, 2017)

被引：0
|
作者：
Guerzoni, Simona [1 ]
Pellesi, Lanfranco [1 ]
Baraldi, Carlo [1 ]
Cainazzo, Michela Maria [1 ]
Negro, Andrea [2 ]
Martelletti, Paolo [2 ]
Pini, Luigi Alberto [1 ,3 ]
机构：
[1] Univ Modena & Reggio Emilia, Policlin Hosp, Dept Diagnost Med Clin & Publ Hlth, Headache & Drug Abuse Res Ctr, Modena, Italy
[2] Sapienza Univ, St Andrea Hosp, Dept Clin & Mol Med, Reg Referral Headache Ctr, Rome, Italy
[3] Univ Modena & Reggio Emilia, Ctr Neurosci & Neurotechnol, Dept Biomed Metab & Neural Sci, Modena, Italy
来源：
FRONTIERS IN NEUROLOGY | 2018年 / 9卷
关键词：
chronic migraine; OnabotulinumtoxinA; long-term treatment; quality of life; tolerance; headache; medication overuse headache;
D O I：
10.3389/fneur.2018.00641
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 35 条
  • [21] Consecutive Headache-Free Days After Long-term Treatment With OnabotulinumtoxinA in Patients With Chronic Migraine: A Post Hoc Analysis of the Pooled PREEMPT Studies
    Diener, H.
    Dodick, D. w
    Lipton, R. B.
    Sommer, K.
    Silberstein, S. D.
    HEADACHE, 2020, 60 : 10 - 10
  • [22] A Preliminary Analysis on the Feasibility and Short-Term Efficacy of a Phase-III RCT on Mindfulness Added to Treatment as Usual for Patients with Chronic Migraine and Medication Overuse Headache
    Grazzi, Licia
    Raggi, Alberto
    Guastafierro, Erika
    Passavanti, Marco
    Marcassoli, Alessia
    Montisano, Danilo Antonio
    D'Amico, Domenico
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (21)
  • [23] Long-term impact of fremanezumab on response rate, acute headache medication use, and disability in chronic migraine patients with acute medication overuse at baseline: results of a 1-year study
    Silberstein, Stephen D.
    Kudrow, David
    Cohen, Joshua M.
    Gandhi, Sanjay K.
    Yang, Ronghua
    Ning, Xiaoping
    Blaiss, Cory
    CEPHALALGIA, 2019, 39 : 214 - 214
  • [24] Long-Term Impact of Fremanezumab on Response Rate, Acute Headache Medication Use, and Disability in Chronic Migraine Patients with Acute Medication Overuse at Baseline: Results of a 1-Year Study
    Silberstein, S. D.
    Kudrow, D.
    Cohen, J. M.
    Gandhi, S. K.
    Yang, R.
    Ning, X.
    HEADACHE, 2019, 59 : 113 - 113
  • [25] Descriptive comparison of the efficacy and safety of onabotulinumtoxina for headache prophylaxis in adult chronic migraine patients from two long-term, multicenter studies: compel vs. Preempt
    Aurora, S.
    Stark, R.
    Reppine, A.
    Adams, A. Manack
    Blumenfeld, A.
    CEPHALALGIA, 2015, 35 : 47 - 47
  • [26] Descriptive Comparison of the Efficacy and Safety of OnabotulinumtoxinA for Headache Prophylaxis in Adult Chronic Migraine Patients from Two Long-term, Multicenter Studies: COMPEL vs. PREEMPT
    Aurora, S.
    Stark, R.
    Reppine, A.
    Adams, Manack A.
    Blumenfeld, A.
    HEADACHE, 2015, 55 : 142 - 142
  • [27] Long-term safety and efficacy of adalimumab therapy in patients with juvenile rheumatoid arthritis (JRA) - Results from over 2 years of treatment
    Ruperto, N.
    Lovell, D. J.
    Goodman, S.
    Reiff, A.
    Nemcova, D.
    Prieur, A. M.
    Joos, R.
    McIlraith, M.
    Martini, Alberto
    Giannini, E.
    RHEUMATOLOGY, 2008, 47 : II2 - II3
  • [28] Clinical efficacy and safety of de novo lamivudine and adefovir dipivoxil combination long-term treatment (≥ 3 years) in patients with chronic hepatitis B
    Zhu, Biao
    Kong, Huiqin
    Zhao, Nianfeng
    Chen, Heling
    Ju, Hongzhen
    HEPATOLOGY, 2012, 56 : 407A - 407A
  • [29] Long-Term Safety, Efficacy, and Adherence of Tralokinumab for the Treatment of Patients with moderate to severe atopic Dermatitis over a Period of up to 3 Years: Interim Analysis of ECZTEND, a Phase III Long-Term Extension Study
    Wollenberg, Andreas
    Blauvelt, Andrew
    Lacour, Jean-Philippe
    Toth, Darryl
    Laquer, Vivian
    Herranz, Pedro
    Pink, Andrew
    Peris, Ketty
    Saeki, Hidehisa
    Beissert, Stefan
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 19 - 20
  • [30] Tofacitinib in the treatment of Indian patients with rheumatoid arthritis: A post hoc analysis of efficacy and safety in Phase 3 and long-term extension studies over 7 years
    Chopra, Arvind
    Shobha, Vineeta
    Chandrashekara, Srikantiah
    Veeravalli, Sarath C. M.
    Sharma, Reena
    Rao, Uppuluri R.
    Pandya, Sapan
    Wagh, Shrikant
    Kadel, Jugal K.
    Thorat, Amit, V
    Adhav, Charles
    Estrella, Paul Santos
    Yu, Wei
    Kwok, Kenneth
    Wouters, Ann
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (07) : 882 - 897
1234